Search research articles
Contact Us
Filters
Showing results (431-440 of 491) with videos related to
Page
of 50
Sort By:
International Wound Journal
|
August 5, 2024
Assessing health-related quality of life using the Wound-QoL-17 and the Wound-QoL-14-Results of the cross-sectional European HAQOL study using item response theory
Toni Maria Janke, Vlastimil Kozon, Skaidra Valiukeviciene, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 2, 2017
S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version
Sonja Ständer, Claudia Zeidler, Matthias Augustin, et al.
Dermatology and Therapy
|
December 9, 2022
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative
Jan Koren, Jo L W Lambert, Simon F Thomsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2026
The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data
Luigi Naldi, Simone Cazzaniga, Carsten Flohr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 18, 2021
Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs
Matthias Augustin, Gefion Girbig, Anne Kis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigo
Lea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Lancet (London, England)
|
August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.
Archives of Dermatological Research
|
March 18, 2019
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study
Irina Gasslitter, Natalia Kirsten, Matthias Augustin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 28, 2019
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
Richard G B Langley, Kristian Reich, Vibeke Strand, et al.
Medicine
|
November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
Katharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Page
of 50
Search research articles
Search
Showing results (431-440 of 491) with videos related to
Sort By:
Page
of 50
International Wound Journal
|
August 5, 2024
Assessing health-related quality of life using the Wound-QoL-17 and the Wound-QoL-14-Results of the cross-sectional European HAQOL study using item response theory
Toni Maria Janke, Vlastimil Kozon, Skaidra Valiukeviciene, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
August 2, 2017
S2k Guidelines for the diagnosis and treatment of chronic pruritus - update - short version
Sonja Ständer, Claudia Zeidler, Matthias Augustin, et al.
Dermatology and Therapy
|
December 9, 2022
Elevating the Standard of Care for Patients with Psoriasis: 'Calls to Action' from Epicensus, a Multistakeholder Pan-European Initiative
Jan Koren, Jo L W Lambert, Simon F Thomsen, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
June 22, 2026
The worldwide burden of skin diseases: Lessons from the Global Burden of Disease data
Luigi Naldi, Simone Cazzaniga, Carsten Flohr, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
|
October 18, 2021
Inpatient care for skin diseases in Germany: multi-source analysis on the current and future health care needs
Matthias Augustin, Gefion Girbig, Anne Kis, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
November 8, 2025
The SWITCH algorithm: An expert consensus on treat-to-target criteria for chronic prurigo
Lea S Stahl, Claudia Zeidler, Joyce Loewenthal, et al.
Lancet (London, England)
|
August 12, 2018
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
Kenneth B Gordon, Bruce Strober, Mark Lebwohl, et al.
Archives of Dermatological Research
|
March 18, 2019
Successful intra-class switching among IL-17 antagonists: a multicentre, multinational, retrospective study
Irina Gasslitter, Natalia Kirsten, Matthias Augustin, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
October 28, 2019
Ixekizumab treatment and the impact on SF-36: results from three pivotal phase III randomised controlled trials in patients with moderate-to-severe plaque psoriasis
Richard G B Langley, Kristian Reich, Vibeke Strand, et al.
Medicine
|
November 19, 2016
Preferences of German melanoma patients for interferon (IFN) α-2b toxicities (the DeCOG "GERMELATOX survey") versus melanoma recurrence to quantify patients' relative values for adjuvant therapy
Katharina C Kaehler, Christine Blome, Andrea Forschner, et al.
Page
of 50